The effects of the R‐Tf‐D‐LP4 peptide on glioblastoma‐derived U‐87MG, lung cancer‐derived A549, or breast cancer‐derived MDA‐MB‐231 cell xenograft mouse models were tested according to an established protocol (Fig. 6A). The gene discussed is TF; the disease is breast carcinoma.